跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMIGAN PF-bimatoprost 300 microgram/ mL single dose ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
LUMIGAN PF-bimatoprost 300 microgram/ mL single dose ampoule
Approved
STANDARD
LUMIGAN PF-bimatoprost 300 microgram/ mL single dose ampoule
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
25bf2b10f6affb54
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
25bf2b10f6affb54
Product Name
LUMIGAN PF-bimatoprost 300 microgram/ mL single dose ampoule
Artg Id
199469
Artg Name
LUMIGAN PF-bimatoprost 300 microgram/ mL single dose ampoule
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2013-05-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02272-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01751-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
25bf2b10f6affb54
Type
Standard
Back to TGA Approvals